Traditional Chinese medicine composition for treating non-small-cell lung cancer hypercoagulability

A technology of non-small cell lung cancer and its composition, which is applied in the field of medicine, can solve the problems of organ bleeding and unfavorable patient prognosis, achieve the effects of relieving TCM symptoms, good drug safety, and improving blood hypercoagulability
CN105056136AInactive Publication Date: 2015-11-18JINAN BANGWEN MEDICAL TECH
1 Cites 1 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
JINAN BANGWEN MEDICAL TECH
Publication Date
2015-11-18
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

The invention belongs to the technical field of medicine, and particularly relates to a traditional Chinese medicine composition for treating non-small-cell lung cancer hypercoagulability. The traditional Chinese medicine is composed of, by weight, 8-16 parts of milkvetch roots, 8-16 parts of roots of woodland beakchervil, 8-16 parts of rhizoma atractylodis macrocephalae, 8-16 parts of salviae miltiorrhizae, 8-16 parts of saffron, 8-16 parts of hirudo, 6-14 parts of fructus aurantii, 6-14 parts of pericarpium citri reticulatae, 6-14 parts of pinellia ternate, 6-14 parts of twigs and leaves of Tibet lyonia, 8-16 parts of angelica sinensis, 8-16 parts of macrocarpa nucuma and 4-8 parts of radix glycyrrhizae. The traditional Chinese medicine composition for treating the non-small-cell lung cancer hypercoagulability can improve the hypercoagulable state of patients with advanced NSCLC and relieve symptoms of traditional Chinese medicine obviously. Obvious changes of blood routine, liver and kidney functions and electrocardiograms do not exist, and the safety of medication is good.
Need to check novelty before this filing date? Find Prior Art

Description

Technical field

[0001] The invention belongs to the technical field of medicine, and specifically relates to a traditional Chinese medicine composition for treating the hypercoagulable state of non-small cell lung cancer. Background technique

[0002] Lung cancer (LC) is the most common malignant tumor in the clinic, and the mortality rate ranks first among all malignant tumors. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Lung cancer patients often have blood hypercoagulability, which is an imbalance of the coagulation-anticoagulation-fiber volume system. If not intervened in time, deep vein thrombosis, pulmonary embolism, cerebrovascular accident, diffuse intravascular coagulation and organs can occur Serious complications such as bleeding are not conducive to the prognosis of patients.

[0003] Therefore, actively preventing hypercoagulability is a problem that cannot be ignored in the treatment of lung cancer. Summary of the invention

[0004] Th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More